Adeline L. Vanderver, MD, director of Children’s National Health System’s Myelin Disorders Clinic has become one of the leaders in an international effort to bring attention to leukodystrophies, a group of diseases that have a high mortality rate among children, with an incidence more common than some widely known disorders.
Catherine M. Bollard, MBChB, MD, director of Children’s National Health System’s Program for Cell Enhancement and Technologies for Immunotherapy (CETI), and her team have performed the hospital’s first treatment using T-cell therapy for a 6-month-old patient with congenital immune deficiency and a life-threatening virus infection.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS), in collaboration with its pediatric clinical partner Children’s National Health System, is pleased to announce that Stephen J. Teach, MD, MPH, will serve as the Chair for the Department of Pediatrics. In this role, Dr. Teach will have oversight of the education and academic activities of faculty in the department.
When parents are in the crucial stages of contemplating treatment for children with life-threatening or terminal illness, among the many sobering questions they ask: am I being a good parent to my seriously ill child?
Washington, DC - More clinical trials, increased patient advocacy, and collective work in a multi-disciplinary consortia of healthcare organizations, are becoming increasingly important “to move forward” rare disease research for children, says Mark L. Batshaw, MD, Physician-in-Chief and Chief Academic Officer for Children’s National Health System.